awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47877975-9AC6B723-38C8-4767-A1EF-2C0B69C0D685
Q47877975-9AC6B723-38C8-4767-A1EF-2C0B69C0D685
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47877975-9AC6B723-38C8-4767-A1EF-2C0B69C0D685
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.
P2860
Q47877975-9AC6B723-38C8-4767-A1EF-2C0B69C0D685
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47877975-9AC6B723-38C8-4767-A1EF-2C0B69C0D685
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4ef275e479eae6f8f0a42e6daed378163b6cc85
P2860
Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.